NDC product
Human Papillomavirus Combination 4019
NDC 63083-4019 · Professional Complementary Health Formulas
Key facts
| Product NDC | 63083-4019 |
|---|---|
| Proprietary name | Human Papillomavirus Combination |
| Nonproprietary name | Human Papillomavirus Combination |
| Substances | HUMAN ADENOVIRUS B SEROTYPE 3, MUSA ACUMINATA WHOLE, HUMAN PAPILLOMAVIRUS SEROTYPE 16 WHOLE |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | Professional Complementary Health Formulas |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Marketing start | Aug 15, 1984 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: